Sign in

CIK 0001817713 · Large accelerated filer

Janux Therapeutics, Inc.

Sign in to watch
Ticker
JANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
822289112
Phone
(858) 751-4493
Business address
10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO, CA, 92130
  1. 424B5 Offering Prospectus
  2. 424B5 Offering Prospectus
  3. 424B5 Offering Prospectus
  4. 424B5 Offering Prospectus
  5. 424B5 Offering Prospectus
  6. 424B5 Offering Prospectus
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. UPLOAD Other SEC-generated Letter
  9. S-3 Offering Registration Statement
  10. 424B4 Offering Prospectus
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. S-1/A Offering Registration Statement
  15. UPLOAD Other SEC-generated Letter
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. S-1 Offering Registration Statement
  18. UPLOAD Other SEC-generated Letter

Page 1 of 1 · 18 filings